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Summary 
c-Jun amino-terminal kinases (JNKs) and mitogen- 
activated protein kinases (MAPKs) are closely related; 
however, they are independently regulated by a variety 
of environmental stimuli. Although molecules linking 
growth factor receptors to MAPKs have been recently 
identified, little is known about pathways controlling 
JNK activation. Here, we show that in COS-7 cells, acti- 
vated Ras effectively stimulates MAPK but poorly in- 
duces JNK activity. In contrast, mutationally activated 
Racl and Cdc42 GTPases potently activate JNK without 
affecting MAPK, and oncogenic guanine nucleotide 
exchange factors for these Rho-Iike proteins selec- 
tively stimulate JNK activity. Furthermore, expression 
of inhibitory molecules for Rho-related GTPases and 
dominant negative mutants of Racl and Cdc42 block 
JNK activation by oncogenic exchange factors or after 
induction by inflammatory cytokines and growth fac- 
tors. Taken together, these findings strongly support 
a critical role for Racl and Cdc42 in controlling the 
JNK signaling pathway. 
Introduction 
Mitogen-activated protein kinases (MAPKs), also known 
as extracellular signal-regulated kinases, are protein- 
serine/threonine kinases that are rapidly activated upon 
stimulation of a variety of cell surface receptors (Ray and 
Sturgill, 1987). Their function is to convert extracellular 
stimuli to intracellular signals controlling the expression 
of genes essential for many cellular processes, including 
cell growth and differentiation (Marshall, 1995). These ki- 
nases play a central role in mitogenic signaling, as imped- 
ing their function prevents cell proliferation in response 
to a number of growth-stimulating agents (Pages et al., 
1993). Furthermore, aberrant functioning of proteins 
known to be upstream of MAPK can induce cells to acquire 
the transformed phenotype, and constitutive activation of 
the MAPK pathway is itself sufficient for tumorigenesis 
(Cowley et al., 1994; Mansour et al., 1994). Thus, MAPKs 
appear to be a critical component of growth-promoting 
pathways. 
Recently, two novel classes of mammalian enzymes 
closely related to MAPKs have been identified. One class 
presents extended similarity to the Saccharomyces cere- 
visiae HOG1 kinase (Han et al., 1994), which is involved 
in protecting S. cerevisiae from hyperosmotic solutions 
(reviewed by Herskowitz, 1995). The role of this mamma- 
lian HOG1 homolog is largely unknown. Although it can 
also be activated by changes in osmolarity, it appears to 
participate in the inflammatory response to lipopolysac- 
charides or to inflammatory mediators such as interleu- 
kin-1 (IL-1) (Han et al., 1994; Freshney et al., 1994). The 
other class of MAPKs represents a family of closely related 
enzymes activated by cellular stress, which have been 
named stress-activated protein kinases (SAPKs) (Kyriakis 
et al., 1994). SAPKs were independently identified by vir- 
tue of their ability to phosphorylate the amino terminus of 
the c-Jun transcription factor; hence, they have been also 
termed c-Jun amino-terminal kinases (JNKs) (D~rijard et 
al., 1994). JNKs can be potently activated by inhibitors of 
protein synthesis such as cycloheximide and anisomycin, 
inflammatory cytokines such as tumor necrosis factor 
(TNFa) and IL-1, changes in osmolarity, heat shock, and 
ultraviolet irradiation (D6rijard et al., 1994; Kyriakis et al., 
1994). JNKs are thought o be responsible for phosphory- 
lating the transactivating domain of c-Jun protein in vivo 
(D~rijard et al., 1994; Kyriakis et al., 1994), and, in turn, 
phosphorylated c-Jun homodimers have potent AP-1 ac- 
tivity and can control the expression of a number of genes, 
including c-jun itself (Angel et al., 1988). 
The mechanism of activation of JNKs has just begun 
tO be explored. Although initial observations suggested 
that these enzymes were located downstream of Ras (D6- 
rijard et al., 1994), this hypothesis is in conflict with recently 
available data (Sun et al., 1994), including'the lack of acti- 
vation of JNK in certain cellular systems by agonists acting 
on receptors that are known to couple to the Ras-MAPK 
pathway (Kyriakis et al., 1994; Coso et al., 1995). Further- 
more, agonists such as TNFa and IL-1 potently induce 
JNK, but they activate MAPK poorly (Kyriakis et al., 1994). 
Taken together, these observations uggest the existence 
of distinct pathways leading to the activation of either 
MAPK or JNK. In this study, we have used the expression 
of hemagglutinin (HA) epitope-tagged JNK1 (HA-JNK) in 
COS-7 cells to explore the mechanism of activation of J N K. 
We present evidence that the small GTP-binding proteins 
Racl and Cdc42 are an integral part of a novel signaling 
pathway linking cell surface receptors to JNK activation. 
Results 
Functional Expression of an Epitope-Tagged JNK 
The JNK1 cDNA was obtained by the polymerase chain 
reaction (PCR)technique, its coding sequence was altered 
by the insertion of an amino-t~rminal tag of 9 amino acids 
representing influenza HA1 protein (Wilson et al., 1984), 
and the cDNA was cloned in the expression vector pcDNA3. 
As shown in Figure 1 (top), this epitope-tagged JNK1 cDNA 
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Figure 1. Expression of an Epitope-Tagged JNK1 in COS-7 Cells 
Lysates containing 40 l~g of protein from COS-7 cells transfected with 
pcDNA3 vector (control) r with an expression plasmid carrying an 
epitope-tagged human JNK1 cDNA (HA-JNK) (1 ~g per plate) were 
subjected to Western blot (WB) analysis with antibodies against HA 
or JNK1, as indicated. Additional lysates containing 800 pg of cellular 
protein were first i mmunoprecipitated with the anti-HA antibody (HA-IP)
and then subjected to the same analysis. Bands were visualized by 
,.4he enhanced chemiluminescence technique using the appropriate 
horseradish peroxidase-conjugated goat antiserum. Arrows indicate 
the position of the epitope-tagged J NK1 protein. Parallel immunopre- 
cipitates from serum-starved cells untreated (minus) or exposed to 
anisomycin (10 l~g/ml; 20 min) (plus) were assayed for JNK activity 
(JNK) ~;~ described in Experimental Procedures, using GST-c-Jun(79) 
or GST-ATF2(96) as substrates. Bands corresponding to the radiola- 
beled substrate are indicated. 
(HA-JNK) was efficiently expressed when transfected into 
COS-7 cells, as judged by its immunodetection with the 
anti-HA murine monoclonal antibody 12CA5 (Wilson et al., 
1984) or with a JNKl-speci f ic  antiserum. Furthermore, 
only HA-JNK-transfected cells exhibited in vitro phosphor- 
ylating activity in an immunocomplex kinase assay, using 
purif ied glutathione S-transferase (GST)-c-Jun(79) or 
GST-ATF2(96) as substrates (Figure 1, bottom). Exposure 
of serum-starved cells to anisomycin, a potent JNK/SAPK 
activator (Kyriakis et al., 1994), induced a striking increase 
in JNK activity (Figure 1, bottom). Thus, this epitope-tagged 
JNK1 encoded by the HA-JNK cDNA construct functions 
as a JNK. 
Activation of JNK Involves a Signaling Route 
Different from That of the 
Ras-MAPK Pathway 
Although a number of studies have demonstrated that the 
activity of c-Jun and JNK is elevated in cells transformed 
by oncogenic ras genes (Angel and Karin, 1991; D~rijard 
et al., 1994; Westwick et al., 1994), many growth factors 
known to activate the Ras-MAPK pathway fail to elevate 
the enzymatic activity of JNK in several cellular systems 
(Kyriakis et al., 1994; Coso et al., 1995). To examine 
whether JNK lies in the same biochemical route as MAPK 
in COS-7 cells, we coexpressed the tagged JNK or MAPK 
alone or together with activated forms of Ras, Raf, and 
MEK. Transfection with the wild-type form of MEK and 
treatment with anisomycin served as controls. As shown 
in Figure 2, activated forms of Ras, Raf, and MEK potently 
induced MAPK activity, while anisomycin induced this ac- 
tivity to a lesser extent and the wild-type MEK lacked a 
demonstrable effect. In contrast, anisomycin potently in- 
duced JNK activity, v-ras induced a modest increase, and 
Raf and both MEK constructs failed to stimulate JNK. 
Thus, in COS-7 cells, v.ras can weakly signal JNK activa- 
tion, however, through a biochemical route different from 
that of the Raf -MEK-MAPK pathway. 
The Small GTP-Binding Proteins Racl and Cdc42 
Can Potently Activate JNK 
The recent observation that two members of the Rho fam- 
ily of small GTP-binding proteins, Racl and Cdc42, can 
bind and activate certain intracellular kinases (Manser et 
al., 1994), a situation analogous to that of Ras acting on 
Raf (see McCormick, 1994), prompted us to explore whether 
this family of GTPases can initiate a pathway leading to 
JNK activation. We began by expressing wild-type and 
activated forms of members of the Rho family of GTP- 
binding proteins in COS--/cells. This family consists of 
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Figure 2. Effect of Activated Ras, Raf, and MEK on MAPK and JNK 
Activity 
COS-7 cells were transfected with pcDNA3-HA-JNK1 (1 I~g per plate) 
or pcDNA3-HA-MAPK (1 pg per plate) for the MAPK (A) or JNK (B) 
assay, respectively, together with pcDNA3 vector (control) r expres- 
sion vectors carrying cDNAs for v-ras, a constitutively active form of 
Raf (BXB-raf) (previously described by Crespo et al., 1994), MEK, or 
the mutationally activated MEK (MEKEE), as indicated (2 I~g per plate 
in each case). Treatment of cells with 10 i~g/ml anisomycin for 20 min 
was used as a control. Kinase reactions or Western blot (WB) analysis 
were performed in anti-HA immunoprecipitates from the correspond- 
ing cellular lysates as described in Experimental Procedures. ~P- 
labeled products are indicated. Slower mobility ~rms of MAPK are 
likely to represent phosphorylated species. Autoradiograms corre- 
spond to representative experiments for MAPK and'JNK assays. Data 
represent the mean _+ SEM of three to five independent experiments, 
expressed as fold increase with respect to vector-transfected cells 
(control). 
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three subfamilies: Rho (RhoA, RhoB, RhoC, and RhoG), 
Rac (Racl and Rac2), and Cdc42 (Cdc42Hs or G25K) 
(reviewed by Hall, 1994). Thus, we engineered expression 
vectors for representative members of these subfamilies, 
including RhoA, Racl, and Cdc42, and their correspond- 
ing activated mutants. The latter were generated by re- 
placing glutamine for leucine in RhoA, Racl, and Cdc42 
(QL mutants) in a position analogous to that of codon 61 
of Ras. Such a mutation has been shown to inhibit the 
GTPase activity of most of these proteins (Bourne et al., 
1991). When transfected into COS-7 cells, RhoA, Racl, 
and Cdc42 were detectably expressed, as judged by 
GTPase-specific antibodies (Figure 3C). However, these 
GTP-binding proteins failed to activate MAPK, although 
v-ras had a very potent effect under the same experimental 
conditions (Figure 3A). In contrast, Rho-related GTPases 
effectively activated JNK, although to a variable extent 
(Figure 3B). Whereas wild-type RhoA and Racl did not 
enhance JNK activity and activated RhoA caused only a 
very modest increase, expression of wild-type Cdc42 or 
the activated forms of Racl and Cdc42 consistently in- 
duced a 5- to 10-fold increase in the in vitro phosphorylat- 
ing activity of JNK. Thus, expression of activated forms 
of Racl and Cdc42 can potently stimulate JNK, but not 
MAPK, activity. In the case of wild-type Cdc42, we ob- 
served that it can elevate JNK activity only if expressed 
at very high levels, thus suggesting that a certain propor- 
tion of wild-type Cdc42 is in an activated state and, if highly 
expressed, that active fraction might be sufficient o trigger 
downstream effectors. 
Oncogenic Guanine Nucleotide Exchange Factors 
for Rho-like Proteins Potently Activate JNK 
Recent observations that two oncogenes, ost and dbl (Hart 
et al., 1991, 1994; Horii et al., 1994), induce in vitro the 
exchange of GDP for GTP on RhoA and Cdc42 have sug- 
gested that these oncogenes can activate in vivo both 
small GTP-binding proteins. In view of our results, we next 
examined whether expression of db/and ost can induce 
JNK activity in COS-7 cells. We constructed expression 
plasmids for the ost (Horii et al., 1994) and the dbl onco- 
gene (onc-db/) (Eva et al., 1988) and for the db/proto- 
oncogene (proto-db/) (Ron et al., 1988). As a control, we 
also expressed the catalytic domain (Cdc25 domain) of 
SOS, a guanine nucleotide xchang~factor (GEF) for Ras 
(Chardin et al., 1993), upon targeting to the plasma mem- 
brane by fusing its coding sequence to that of the amino- 
terminal myristoylation signal from c-Src (Takeya and Ha- 
nafusa, 1983). As expected, when expressed in COS-7 
cells, the myristoylated Cdc25 domain of SOS was local- 
ized to the plasma membrane fraction (data not shown) 
and potently induced MAPK (Figure 4), but it had little 
effect on JNK. In contrast, transfection of COS-7 cells with 
expression vectors carrying the cDNA for the ost, onc-dbl, 
or proto-dbloncogene did not affect MAPK functioning, but 
induced a remarkable increase in JNK enzymatic activity, 
Which was nearly as great as that caused by exposing 
cells to anisomycin (Figure 4). Therefore, we conclude that 
Racl and Cdc42 Rho-like GTP-binding proteins and their 
exchange factors can effectively induce pathways leading 
to the activation of JNK. 
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Figure 3. Racl and Cdc42 Can Induce JNK 
Activity but Fail to Activate MAPK 
(A and 13) COS-7 cells were transfeoted with 
pcDNA3 vector (control) or with the same ex- 
pressi6n vector carrying cDNAs for the wild- 
type or activated (QL) forms of RhoA, Racl, or 
Cdc42 (2 Ilg per plate in each case). Cells were 
transfected with the indicated expression plas- 
raids together with pcDNA3-HA-MAPK or 
pcDNA3-HA-JNK (1 p.g per plate) for MAPK (A) 
or JNK (B) assay, respectively. Cell extracts 
were processed as in Figure 2. Data represent 
the mean _+ SEM of four independent experi- 
ments, expressed as fold increase with respect 
to vector-transfected cells (control). 
(C) Lysates from transfected cells containing 
40 p.g of total cellular protein (left) or 1 p_g of 
purified bacterially expressed GST-HA-Ras 
(Ras), GST-RhoA (RhoA), GST-Racl (Racl), 
and GST-Cdc42 (Cdc42) fusion proteins (right) 
were subjected to Western blot analysis with 
the corresponding antibodies. 
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Figure 4. Activation of JNK by Expression of GEFs for the Rho Family 
of Small GTP-Binding Proteins 
COS-7 cells were transfected with the indicated expression plasmids 
for ost, onc-dbl, and proto-dbl and for the Cdc25 domain of SOS fused 
to the c-Src amino-terminal myristoylation signal (see Experimental 
Procedures) (2 p.g per plate in each case), together with plasmids 
carrying HA-MAPK or HA-JNK1 for MAPK (A) or J NK (B) immunocom- 
plex kinase assay, respectively. Cells cotransfected with the pcDNA3 
vector (control) untreated or stimulated with anisomycin (10 p.g/ml; 20 
min) served as controls. Cell extracts were processed as in Figure 2. 
Data represent he mean _ SEM of three independent experiments, 
expressed as fold increase with respect to vector-transfected cells 
(control). Expression of each exchange factor was confirmed by West- 
ern blotting with the corresponding antibodies (data not shown). 
Inhibitory Molecules for Rho-like GTPases Block 
JNK Activation Induced by a Variety of Stimuli 
Because we have shown that Racl and Cdc42 each po- 
tently induce J NK activity, we set out to investigate whether 
these small GTP-binding proteins participate in signaling 
from cell surface receptors to JNK. As a general approach, 
we took advantage of the observation that guanine nucleo- 
tide dissociation inhibitors (GDIs) and GTPase-activating 
proteins (GAPs) for this family of GTP-binding proteins 
can inhibit the functioning of RhoA, Racl, and Cdc42 in 
vitro and in vivo (Ueda et al., 1990; Ridley et al., 1993; 
Nishiyama et al., 1994; reviewed by Boguski and McCor- 
mick, 1993; Hall, 1994; Lamarche and Hall, 1994). Initially, 
we engineered expression plasmids carrying RhoGDI (Fu- 
kumoto et al., ! 990) and the catalytic domain of the p190 
RhoGAP (RhoGAPd p190) (Settleman et al., 1992b). The 
latter was expressed either in isolation or fused to the 
amino-terminal myristoylation signal from c-Src (myr Rho- 
GAPd p190). As shown in Figure 5, coexpression of these 
inhibitory molecules for all Rho-like proteins blocked the 
activation of J N K induced by onc-db/; however, they failed 
to inhibit JNK stimulation by Cdc42-QL. Under identical 
conditions, FlhoGDI and both RhoGAP constructs abol- 
ished JNK stimulation by ost but had no effect on this 
response when elicited by Racl-QL (data not shown). 
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Figure 5. EffectofCoexpressinglnhibitoryMoleculesforRho-Related 
GTPases on JNK Activation 
COS-7 cells were transfected with expression plasmids for onc-dbl, 
cdc42-QL, or v.ras (1 pg per plate in each case) together with pcDNA3 
vector without insert (lanes 1) or carrying cDNAs for RhoGDI (1 p.g per 
plate) (lanes 2) or the RhoGAP domain of the p190 RasGAP-associated 
protein, either alone (RhoGAPd p190) (0.5 p.g per plate) (lanes 3) or 
fused to the c-Src amino-terminal myristoylation signal (myr RhoGAPd 
p190) (0.5 p,g per plate) (lanes 4), as indicated. JNK (A) or MAPK 
(B) activity was determined in anti-HA immunoprecipitates from cells 
cotransfected with e indicated expression plasmids and pcDNA-HA- 
JNK or pcDNA-HA-MAPK, respectively. Cells transfected with the indi- 
cated expression plasmids and empty vector wer.p serum starved and 
then were stimulated with EGF (100 ng/ml; 15 rain), TNFa (10 p.g/ml; 
15 min), or anisomycin (10 p.g/ml; 20 rain), as indicated. Cell extracts 
were processed as in Figure 2. Data represent he mean _+ SEM of 
three to five independent experiments, expressed as fold increase 
with respect to vector-transfected cells (control). The letter C indicates 
lysates of transfected COS-7 cells that were analyzed by Western 
blotting with the indicated antibodies. Cotransfected DNAs did not 
affect the expression of HA-MAPK, HA-JNK, Cdc42-QL, or onc-Dbl 
(data not shown). 
Thus, expression of inhibiting molecules for Rho-like pro- 
teins blocks JNK activation by oncogenic exchange fac- 
tors, but does not prevent coupling of constitutively active 
forms of Racl and Cdc42 to their downstream targets. 
Interestingly, molecules inhibiting Rho-like GTPases also 
blocked the activation of JNK by v-ras (Figure 5). In con- 
trast, they had nearly no effect on v-ras-induced MAPK 
activation (Figure 5). This observation further demon- 
strates the specificity of this experimental approach and 
raises the possibility of the existence of a pathway commu- 
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nicating Ras with the Rho family of small GTP-binding 
proteins. 
We next examined the effect of RhoGDI and RhoGAP 
proteins on JNK activation in response to agonists acting 
through receptors endogenously expressed in COS-7 
cells. We initially found that TNFa (10 p.g/ml) and epider- 
mal growth factor (EGF) (100 ng/ml) were both able to 
activate JNK (Figure 5). As shown in Figure 5, coexpres- 
sion of inhibiting molecules for Rho-related proteins po- 
tently blocked stimulation of JNK by both agonists, but 
they had little effect on the JNK activity induced by aniso- 
mycin when used as a control. In contrast, RhoGDI, Rho- 
GAPd p190, and myr RhoGAPd p190 did not significantly 
affect the MAPK response to EGF (Figure 5). Thus, inhibi- 
tory proteins for Rho-related GTPases selectively prevent 
coupling of TNFa and EGF receptors to the JNK pathway. 
Dominant Negative Mutants of Racl and Cdc42 
Inhibit Signaling from Cell Surface Receptors 
to JNK 
To determine which Rho-related GTPase participates in 
signaling to JNK, we have made use of dominant negative 
mutants for RhoA, Racl, and Cdc42. In each case, we 
replaced threonine for asparagine in a position analogous 
to codon 17 of Ras, thus generating N19RhoA, N17Rac1, 
and N17Cdc42, respectively. By analogy to the activity of 
N17Ras, these inhibitory mutants are thought to act by 
competitively inhibiting the interaction of endogenous 
GTP-binding proteins with their respective G EFs (Feig and 
Cooper, 1988). When transfected into COS-7 cells, each 
mutated GTPase was found to be detectably expressed 
(data not shown). We next examined the ability of N 19RhoA, 
N17Racl, and N17Cdc42 to affect JNK activation by stress- 
inducing agents or by agonists acting on cell surface re- 
ceptors. As shown in Figure 6, none of these inhibitory 
mutants affected the JNK response to anisomycin. In con- 
trast, expression of N17Rac1 and N17Cdc42 potently 
blocked the JNK activation elicited by EGF (Figure 6), but 
did not affect the MAPK response to this growth factor 
(data not shown). N17Racl and N17Cdc42 also dimin- 
ished JNK stimulation produced by TNFa (Figure 6). How- 
ever these mutated GTPases were less effective as block- 
ers than the inhibitory proteins utilized in the experiments 
shown in Figure 5, thus raising the possibility that addi- 
tional GTP-binding proteins might also participate in sig- 
naling from TNFa receptor to JNK. In addition, neither 
N19RhoA, N17Rac1, nor N17Cdc42 had any demonstra- 
ble effect on JNK stimulation by Racl-QL and Cdc42-QL, 
th us suggesting that each GTPase can cou pie to the down- 
stream effector(s) in an independent manner. 
We also examined whether Ras plays a role in signaling 
JNK activation by extracellular stimuli, using a dominant 
negative mutant of Ras (N17Ras) (Feig and Cooper, 1988). 
We found that the JNK response to TNFm anisomycin, 
Racl-QL, and Cdc42-QL was not affected by N 17Ras, but 
that this molecule abolishes signaling from EGF receptors 
to both JNK and MAPK (Figure 6; Crespo et al., 1994). 
Thus, taken together these findings demonstrate that tyro- 
sine kinase receptors require functioning of Ras and Racl, 
Cdc42, or both to activate JNK. 
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Figure 6. Effect of Dominant Negative Mutants of Ras, RhoA, Racl, 
and Cdc42 on JNK Activation 
COS-7 cells were transfected with empty vector (top) or expression 
plasmids for Racl-QL and Cdc42-QL (1 lig per plate in each case, 
where indicated) together with pcDNA3 vector without insert (bars 1) 
or carrying cDNAs for N17Ras (0.5 p~g per plate) (bars 2), N19RhoA 
(1 rig per plate) (bars 3), N 17Racl (1 p.g per plate) (bars 4), or N 17Cdc42 
(1 lig per plate) (bars 5) together with pcDNA3-HA-J NK. Serum-starved 
cells were stimulated with EGF (100 ng/ml; 15 rain), TNF~ (10 i~g/ml; 
15 min), or anisomycin (10 p~g/ml; 20 rain), as indicated, and processed 
for immunocomplex JNK assays as described in Figure 2. Data rep- 
resent he mean _+ SEM of three to five independent experiments, 
expressed as fold increase with respect o vector-transfected cells 
(control). 
Discussion 
A large number of extracellular stimuli can potently acti- 
vate JNK, including inflammatory cytokines, certain growth 
factors, G protein-coupled receptors, protein synthesis 
inhibitors, changes in osmolarity, ultraviolet light, et cetera 
(D~rijard et al., 1994; Kyriakis et al., 1994; Coso et al., 
1995). Many of these agents also weakly activate MAPKs. 
Conversely, potent MAPK stimulants uch as phorbol es- 
ters and growth-promoting agents acting on tyrosine ki- 
nase receptors fail to activate JNK in a number of cell 
types (Kyriakis et al., 1994; Coso et al., 1995). Thus, the 
emerging picture is that JNK is regulated independently of 
MAPKs. In this regard, expression of constitutively active 
oncogenic forms of ras has been shown to induce MAPK 
potently but to raise JNK phosphorylating activity to a 
much more limited extent (D~rijard et al., 1994; Sun et al., 
1994). In line with these observations, transient expres- 
sion of v-ras in COS-7 cells potently activated an epitope- 
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tagged MAPK (Crespo et al., 1994; this study), but had 
little effect on an epitope.tagged JNK. Furthermore, con- 
stitutively activated forms of molecules connecting Ras to 
MAPK dramatically activated MAPK, but did not have any 
demonstrable ffect on JNK. Under the same experimen- 
tal conditions, exposure of cells to a protein synthesis 
blocker, anisomycin, elicited a marked increase of JNK 
activity, but weakly stimulated the epitope-tagged MAPK. 
Thus, our results in COS-7 cells are consistent with those 
recently reported in NIH 3T3 (Yan et al., 1994), HeLa, and 
PC12 cells (Minden et al., 1994) and provide compelling 
evidence that the pathway communicating Ras to JNK is 
different from that controlling MAPKs. 
These observations raise the possibility that proteins 
other than Ras may directly regulate biochemical path- 
ways leading to the activation of JNK. In this regard, the 
Ras superfamily of GTPases comprises more than 50 
members, which have been divided into six families based 
upon sequence similarity: Rab, Arf, Sar, Ran, Rho, and 
Ras (see Lamarche and Hall, 1994). Whereas the Rab, 
Arf, and Sar groups have been shown to participate in the 
transport of proteins and vesicles among different intracel- 
lular compartments (Boguski and McCormick, 1993; Hall, 
1994), the Ras family is involved in growth control (see 
below). The Rho family of GTP-binding proteins consists 
~f  the Rho, Rac, and Cdc42 subfamilies and has been 
shown to regulate several aspects of cytoskeleton func- 
tioning (reviewed by Hall, 1994). The Rho subfamily has 
at least four members, RhoA, RhoB, RhoC, and RhoG. 
RhoA has been shown to participate in the formation of 
actin stress fibers, as well as in mediating redistribution 
of cytoskeletal components (Ridley and Hall, 1992; Hall, 
1994). The Rac subfamily includes Racl and Rac2, and 
Racl has been shown to be involved in membrane ruffling 
(Ridley et al., 1992). The Cdc42 group consists of Cdc42Hs 
(referred to here as Cdc42) and G25K (see Hall, 1994), 
and its function in mammalian cells is still largely unknown. 
Ras has been shown to play a central role in cell prolifer- 
ation and differentiation. At the molecular level, Ras ex- 
changes GDP for GTP upon activation of Ras-specific 
GEFs, and in the GTP-bound state, Ras physically associ- 
ates with the amino-terminal domain of Raf (Vojtek et al., 
1993). This process recruits Raf to the plasma membrane, 
allows the activation of Raf by a still unknown mechanism 
(see McCormick, 1994), and initiates asequential cascade 
of kinases leading to MAPK activation. Interestingly, it has 
been recently reported that GTP-bound forms of the Rho- 
related proteins Racl and Cdc42 can specifically associ- 
ate and activate a novel serine/threonine kinase, the p21- 
activated kinase (PAK) (Manser et al., 1994). This situation 
is highly analogous to that of the Ras-Raf interaction, thus 
suggesting that the Rho family of GTP-binding proteins 
might also initiate activity of a kinase cascade (Manser et 
al., 1994). This observation and the failure of Ras fully to 
activate JNK prompted us to ask whether the Rho family 
of GTPases participates in signaling to the JNK pathway. 
Our findings demonstrate that expression of activated 
forms of Racl and Cdc42 can efficiently stimulate JNK 
without affecting MAPK activity. Interestingly, although ac- 
tivated RhoA is known to induce the most dramatic 
changes in the cytoskeletal structure (Ridley and Hall, 
1992; data not shown), it stimulates JNK very poorly. Fur- 
thermore, we have found that treatment of cells with cy- 
toskeletal-disrupting agents such as cytochalasin D fails 
to block JNK activation induced by Racl and Cdc42 (our 
unpublished data). We conclude that Racl and Cdc42 can 
effectively stimulate signaling pathways leading to JNK 
activation, probably through a mechanism distinct from 
that involved in cytoskeletal reorganization. 
The functioning of Rho-like GTP-binding proteins is 
tightly regulated in vivo by proteins that control their GDP/ 
GTP state. GAPs (reviewed by Lamarche and Hall, 1994) 
and GDIs (Ueda et al., 1990) are negative modulators, 
whereas GEFs (Boguski and McCormick, 1993) promote 
the exchange of GDP for GTP, thus activating Rho-like 
proteins. Based upon our results, we asked whether GEFs 
for Rho-related GTPases were also capable of inducing 
JNK activity. Two GEFs for this family have been de- 
scribed: the protein products of the ost and onc-dbl onco- 
genes (Hart et al., 1991 ; Horii et al., 1994). Our data dem- 
onstrate that both exchange factors for Rho-like proteins 
can potently induce JNK activity. In addition, it was notice- 
able that both oncogenic exchange factors poorly induced 
MAPK in COS-7 cells, similar to that previously reported 
for dbl and vav in NIH 3T3 cells (Khosravi-Far et al., 1994). 
Conversely, we have observed that a plasma membrane- 
targeted catalytic (Cdc25-1ike) domain of SOS greatly in- 
duces MAPK, but has a minimal effect on JNK. Taken 
together, these data provide additional evidence that mol- 
ecules activating the Ras pathway preferentially stimulate 
MAPKs and establish that proteins acting on Rho-related 
GTPases can efficiently signal to JNK. 
A number of RhoGAPs have been identified and have 
been shown to display variable specificity with respect to 
their activity on each member of the Rho family (Lamarche 
and Hall, 1994). For example, RhoGAPd p190, a RasGAP- 
associated protein (Settleman et al., 1992a), can stimulate 
in vitro the GTPase activity of RhoA, Racl, and Cdc42 to 
a comparable extent (Lamarche and Hall, 1994). RhoGDI 
forms a cytosolic complex preferentially with GDP-bound 
forms of RhoA, Racl, and Cdc42 (Ueda et al., 1990; Sa- 
saki et al., 1993; Hall, 1994), thus preventing their activa- 
tion. Both GAPs and GDIs have proven to be useful tools 
for blocking the function of Rho-related GTPases in a vari- 
ety of biological systems (Ridley et al., 1993; Nishiyama 
et al., 1994; Hall, 1994); thus, we utilized their expression 
as a simple approach to investigate a role for Rho-related 
proteins in the JNK signal transduction pathway. Here, 
we show that expression of RhoGDI and RhoGAPd p190 
as well as a mem brane-targeted RhoGAPd p 190 (myr Rho- 
GAPd p190) effectively block JNK activation by ost and 
dbl. In contrast, these inhibitory molecules for Rho-related 
GTPases failed to block JNK stimulation by the muta- 
tionally activated Cdc42. This observation is consistent 
with the finding that RhoGDI poorly associates with GTP- 
bound proteins of the Rho family (Sasaki et.al., 1993) and 
with the lack of effect of GAPs on mutationally activated 
proteins of the Ras superfamily (McCormick et al., 1991). 
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It also demonstrates that neither RhoGDI nor RhoGAPd 
p190 exerts a direct inhibitory effect on JNK. In addition, 
Rho-blocking proteins prevented JNK activation by v-ras, 
EGF, and TNFa, but did not affect signaling from EGF 
receptors or v-ras to MAPK. These findings further support 
the specificity of this approach and provide strong evi- 
dence that Ras, as well as EGF and TNFa receptors, sig- 
nals to JNK through Rho-related GTPases. 
To establish the identity of the endogenously expressed 
GTP-binding protein(s) that participates in linking cell sur- 
face receptors to JNK, we made use of dominant negative 
mutants for each class of GTPases, Ras, RhoA, Racl, 
and Cdc42. We found that the dominant negative mutant 
of Ras effectively prevents MAPK (Crespo et al., 1994) and 
JNK activation by EGF, but not JNK stimulation induced 
by either TNF~ or anisomycin. Thus, functioning of Ras 
appears to be strictly required for linking EGF receptors 
to JNK, whereas other stimuli utilize Ras-independent 
pathways. In this regard, we have found that the dominant 
negative mutants of Racl and Cdc42 effectively reduce 
JNK stimulation elicited by both EGF and TNFm sug- 
gesting that the pathway connecting TNF~ and EGF re- 
ceptors to JNK involves Racl and Cdc42 or, alternatively, 
a common GEF acting on either GTPase. Thus, taking 
the inhibitory action of N 17Rac1 and N17Cdc42, the block- 
ade of JNK activation upon expression of negative regula- 
tors of Rho-related proteins, and the pattern of JNK stimu- 
lation by mutationally activated GTPases, we conclude 
that the small GTP-binding proteins Racl and Cdc42 are 
an integral part of the biochemical route linking cell SUrface 
receptors to JNK. 
The JNK response to anisomycin was not affected by 
inhibitors of Rho-related proteins, nor by N17Rac1 or 
N17Cdc42, thus suggesting that cell-stressing stimuli 
might induce JNK activity independently of these GTP- 
binding proteins. On the other hand, expression of the 
inhibitory mutants of RhoA, Racl, or Cdc42 did not affect 
JNK stimulation by constitutively activated Racl and 
Cdc42, which is not consistent with the existence of a 
hierarchically arranged cascade of GTPases, as recently 
reported for cytoskeletal regulation (Ridley and Hall, 1992; 
Ridley et al., 1992; Nobes and Hall, 1995). Instead, these 
results strongly suggest that each GTPase, Racl and 
Cdc42, can activate effector pathways independently. 
Whether PAK or a PAK-related kinase, which can bind 
either Racl or Cdc42, is immediately downstream of these 
GTPases in the biochemical route to JNK warrants further 
investigation. 
The emerging picture from our study and from recent 
reports (Minden et al., 1994; Sanchez et al., 1994; Yan 
et al., 1994; D~rijard et al., 1995) is that mammalian cells 
have independent signaling pathways connecting cell sur- 
face receptors with each member of the MAPK superfam- 
ily. This situation is remarkably similar to that of the bud- 
ding yeast S. cerevisiae, in which genetic studies have 
revealed the existence of parallel cascades of kinases 
leading to the activation of at least three distinct MAPK- 
related enzymes (reviewed by Herskowitz, 1995). In the 
case of the mating pheromone response, extracellular li- 
gands (~ or a factors) activate cell surface receptors that 
in turn induce the dissociation of a heterotrimeric G protein 
into a (GPA1) and I~' (Ste4 and Ste18) subunits (reviewed 
by Bardwell et al., 1994; Herskowitz, 1995; see Figure 7). 
Free J37 dimers then activate a serine/threonine kinase, 
Ste20 initiating activity from a linear cascade of kinases, 
including, sequentially, Stel 1 and Ste7, which phosphory- 
late and activate the yeast MAPK homologs Fus3 and Kssl 
(Figure 7). As discussed above, JNK and MAPK are highly 
related to each other and to the budding yeast MAPKs. 
Four mammalian homologs of Ste7 have been identified, 
two of them (MEK1 and MEK2) specifically activate MAPK 
(Crews et al., 1992), and one (designated SEK [Sanchez 
et al., 1994] or MKK4 [Derijard et al., 1995]) directly phos- 
phorylates and activates JNK. The known mammalian 
budding yeast mammalian 
cells 
pheromone 
others 
GTP-binding F protein L Rho-like (?) 
G-protein 
cytokines and tyrosine 
others kinaee-linked 
•.."  receptors 
Rac1-Cdc42 -q--- ? . . . . .  Ras ] 
MAPKKKK I sT,2° I ..---"""" 
MAPKKK I STE11. MEKK Raf ] 
MAPKK [ STE.7 SEK MEK ] 
MAPK IFUS3, KSS1 SAPK(JNK) MAPK I 
mating functions stress responses mitogenesis 
invasive growth growth arrest differentiation 
morphology apoptosis? 
Figure 7. Schematic Representation of Protein Kinase Cascades 
Leading to the Activation of Distinct Members of the MAPK Superfamily 
Accumulating evidence suggests that parallel kinase cascades control 
the activity of MAPK and JNK. Following the mating pheromone re- 
sponse pathway in S. cerevisiae as an example of such a multicompo- 
nent signaling route, each level of the cascade can be functionally 
defined as MAPK, MAPKK, MAPKKK, and MAPKKKK, represented 
in this case by Fus3/Kssl, Ste7, Ste11, and Ste20, respectively, as 
depicted (see Herskowitz, 1995). In the mammalian MAPK pathway, 
only three levels have been identified, represented by MAPK, MEK, 
and Raf (see Marshall, 1995). In the mammalian JNK signaling route, 
JNK, SEK, and MEKK represent he first three hierarchical levels (see 
text for details), and we postulate that PAK (Manser et al., 1994 ) or 
related enzymes represent he most upstream kinase in this cascade. 
Whether that is the case remains to be established. Activity of these 
kinase cascades is tightly regulated. Ras controls mammalian MAPK 
by acting directly on Raf. Our study has shown that the small GTP- 
binding proteins Racl and Cdc42 regulate the JNK pathway. Rho- 
related GTPases have been previously suggested to regulate the activ- 
ity of budding yeast Ste20 or of its newly identified homologous 
proteins (see Bardwell et al. 1994), although biochemical evidence 
is still missing. Broken lines represenl potential cross-talks among 
signaling systems. The pathway connecting cell surface receptors to 
low molecular weight GTP-binding proteins and the identity of biologi- 
cally relevant targets ,for these kinase cascades are yet to be fully 
elucidated. 
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functional homologs of Ste11 are Raf and MEK kinase 
(MEKK) (Lange-Carter et al., 1993). Raf is located up- 
stream of MEK, thus defining a linear kinase cascade rep- 
resented by the Raf -MEK-MAPK signaling module, 
whose activity is dependent on Ras (see above). MEKK 
is closely related to Stel 1 by primary sequence similarity, 
and two different groups have recently observed that 
MEKK functions preferentially in the JNK pathway, specifi- 
cally controlling SEK activity (Yan et al., 1994; Minden et 
al., 1994). The identity of molecules that directly regulate 
MEKK is still unknown, in this regard, a mammalian homo- 
log of Ste20 has been recently isolated, p65 pAK (Manser 
et al., 1994), and it has been shown that Ste20 and PAKs 
are activated upon interaction with GTP-bound forms of 
Racl  and Cdc42. Taken together, these observations and 
our present results demonstrating that Racl  and Cdc42 
can regulate the activity of JNK enable us to postulate 
that either PAK or related kinases link Racl  and Cdc42 
to the MEKK-SEK- JNK module (Figure 7). Such a hypoth- 
esis linking small GTP-binding proteins of the Rho family 
to the JNK signaling pathway is testable and will be the 
target  for future investigation. 
Experimental Procedures 
~ Expression Plasmids 
JNK1 cDNA (D~rijard et al., 1994) was obtained by the PCR technique 
using as a template human skeletal muscle cDNA (Invitrogen) and 
was cloned into the Bglll and Sail sites of pcDNA3-HA, a modified 
pcDNA3 expression plasmid (Invitrogen) encoding the HA nonapep- 
tide epitope (Wilson et al., 1984; J. S. G., unpublished ata). 
The previously described cDNAs for human RhoA, Racl, and 
Cdc42Hs (referred to in this paper as Cdc42) GTP-binding proteins 
(Horii et al., 1994) were cloned in pcDNA3 as BamHI-EcoRI fragments. 
Their respective constitutively activated mutants were obtained by re- 
placing a glutamine residue corresponding to codon 63 of RhoA or 
codon 61 of Ract and Cdc42 for a leucine residue (QL mutants), using 
PCR-directed mutagenesis. Dominant negative mutants for each small 
GTP-binding protein were obtained by replacing threonine for aspara- 
gine in a position analogous to codon 17 of Ras, generating N19RhoA, 
N17Rac1, and N17Cdc42. 
Wild-type MEK1 (Crews et al., 1992) (provided by R. Erickson) was 
cloned into the pcDNA3 vector as a BamHI-Notl fragment. Activated 
MEK1 was generated by replacing Ser-218 and Ser-222 by glutamic 
acid; this construct was designated MEKEE (Cowley et al., 1994). A 
f .4 kb DNA fragment encoding the Cdc25 domain of the human SOS 
protein (codons 568-1042) was amplified by PCR using human SOS 
cDNA (Chardin et al., 1993) as a template and was subcloned into 
pcDNA3-myr, a modified pcDNA3 expression plasmid encoding the 
amino-terminal 21 amino acids of chicken c-Src (Takeya and Hana- 
fusa, 1983), which includes the c-Src amino-terminal myristoylation 
signal (H. T. and J. S. G., unpublished ata). Onc-dbl and proto-dbl 
cDNAs (Eva et al., 1988; Ron et aL, 1988) were subcloned as BamHI 
fragments in the pcDNA3 expression vector. A 1.1 kb DNA fragment 
encoding the RhoGAP domain of human p190 protein associated to 
RasGAP (Settleman et al., 1992b) (codons 1177-1512) was amplified 
by PCR using rat brain cDNA and appropriate oligonucleotides and 
was subcloned into pcDNA3-KZ, a modified pcDNA3 vector containing 
an efficient ranslational initiation sequence as described by Kozak 
(1989) upstream of an artificial initiation codon in-frame with the BamHI 
site (O. A. C. and J. S. G., unpublished data) or pcDNA3-myr (see 
above). RhoGDI (Fukumoto et al., 1990) (provided by Y, Takai) was 
subcloned as a BamHI-EcoRI fragment into the pcDNA3-KZ vector. 
In all cases, nucleotide sequences of wild-type and mutated cDNAs 
were verified by DNA sequencing. The sequence of oligonucleotides 
utilized for each DNA construct will be made available upon request, 
Kinase Assays 
JNK Assay 
Subconfluent COS-7 cells were transfected with pcDNA3-HA-JNK and 
additional DNAs by the DEAE-dextran technique. Total amount of 
plasmid DNA was adjusted to 5-10 p.g per plate with vector DNA 
(pcDNA3; Invitrogen) when necessary, and 2 days later, transfected 
COS-7 cells were cultured overnight in serum-free medium. Cells were 
then left untreated or stimulated with various agents, washed with cold 
PBS, and lysed at 4°C in a buffer containing 25 mM HEPES (pH 7.5), 
0.3 M NaCI, 1.5 mM MgCI2, 0.2 mM EDTA, 0.5 mM D'l-r, 1% Triton 
X-100, 0.5% sodium deoxycholate, 0.1% SDS, 20 mM ~-glycem- 
phosphate, 1 mM sodium vanadate, 1 mM phenyimethylsulfonyifluo- 
ride, 20 p.g/ml aprotinin, and 20 pg/ml leupeptin. The epitope-tagged 
JNK was immunoprecipitated from the cleared lysates by incubation 
with the specific antibody 12CA5 (BABCO) for 1 hr at 4°C. Immuno- 
complexes were recovered with the aid of Gamma-Bind 8epharose 
beads (Pharmacia) and washed three times with PBS containing 1% 
NP-40 and 2 mM sodium vanadate, once with 100 mM Tris (pH 7.5), 
0.5 M LiCI, and once with kinase reaction buffer (12.5 mM MOPS [pH 
7.5], 12.5 mM ~-glycerophosphate, 7.5 mM MgCI2, 0.5 mM EGTA, 
0.5 mM sodium fluoride, 0.5 mM sodium vanadate). The JNK activity 
present in the immunoprecipitates was determined by resuspension 
in 30 p.I of kinase reaction buffer containing 1 i~Ci of [~,-~P]ATP per 
reaction and 20 pM unlabeled ATP, using 1 p.g of GST-c-Jun(79) or 
GST-ATF2(96) fusion protein as a substrate, as previously described 
(Coso et al., 1995). After 20 rain at 30°C, reactions were terminated 
by addition of 10 pl of 5x Laemmli's buffer. Samples were heated at 
95°C for 5 rain and analyzed by SDS electrophoresis on 12% polyacryl- 
amide gels. Autoradiography was performed with the aid of an intensi- 
fying screen. Parallel anti-HA immunoprecipitates were processed for 
Western blot analysis using a JNK-specific antiserum. 
MAPK Assay 
MAPK activity in COS-7 cells transfected with an epitope-tagged MAPK 
(HA-ERK2, referred to here as HA-MAPW) was determined as pre- 
viously described (Crespo et al., 1994), using myelin basic protein as 
a substrate. Parallel samples were immunoprecipitated with anti-HA 
antibody and processed for Western blot analysis using a MAPK- 
specific antiserum. 
Western Blots 
• Lysates containing approximately 40 p~g.of total cellular protein or 
anti-HA immunoprecipitates were analyzed by Western blotting after 
SDS-polyacrylam ide gel electrophoresis, transferred to nitrocelldlose, 
and immunoblotted with the corresponding rabbit antiserum or mouse 
monoclonal antibody. Immunocomplexes were visualized by en- 
hanced chemiluminescence detection (Amersham) using goat anti- 
rabbit or anti-mouse antiserum coupled to horseradish peroxidase as 
a secondary antibody (Cappel). Mouse monoclonal antibodies anti-HA 
epitope clone 12CA5 and anti-p190 were purchased from BABCO and 
from Transduction Laboratories, respectively. Rabbit polyclonal anti- 
sera anti-JNK1, anti-RhoA, anti-Racl, anti-Cdc42, anti-RhoGDI, and 
anti-c-Src were purchased from Santa Cruz Laboratories, In all cases, 
specificity was confirmed using a battery of bacterially produced re- 
combinant proteins (Figure 3; data not shown)• 
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